- Home
- VVPR vs AIMD Comparison
VVPR vs AIMD Comparison
Compare VVPR & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VVPR
- AIMD
- Stock Information
- Founded
- VVPR 2014
- AIMD 1984
- Country
- VVPR United Kingdom
- AIMD United States
- Employees
- VVPR N/A
- AIMD N/A
- Industry
- VVPR Power Generation
- AIMD Biotechnology: Pharmaceutical Preparations
- Sector
- VVPR Utilities
- AIMD Health Care
- Exchange
- VVPR Nasdaq
- AIMD Nasdaq
- Market Cap
- VVPR 6.9M
- AIMD 6.0M
- IPO Year
- VVPR 2016
- AIMD N/A
- Fundamental
- Price
- VVPR $0.90
- AIMD $0.44
- Analyst Decision
- VVPR
- AIMD
- Analyst Count
- VVPR 0
- AIMD 0
- Target Price
- VVPR N/A
- AIMD N/A
- AVG Volume (30 Days)
- VVPR 720.2K
- AIMD 205.1K
- Earning Date
- VVPR 12-03-2024
- AIMD 11-06-2024
- Dividend Yield
- VVPR N/A
- AIMD N/A
- EPS Growth
- VVPR N/A
- AIMD N/A
- EPS
- VVPR N/A
- AIMD N/A
- Revenue
- VVPR $12,237,000.00
- AIMD $40,633.00
- Revenue This Year
- VVPR $818.06
- AIMD N/A
- Revenue Next Year
- VVPR N/A
- AIMD N/A
- P/E Ratio
- VVPR N/A
- AIMD N/A
- Revenue Growth
- VVPR N/A
- AIMD N/A
- 52 Week Low
- VVPR $0.72
- AIMD $0.40
- 52 Week High
- VVPR $9.90
- AIMD $4.29
- Technical
- Relative Strength Index (RSI)
- VVPR 50.05
- AIMD 41.77
- Support Level
- VVPR $0.75
- AIMD $0.41
- Resistance Level
- VVPR $1.35
- AIMD $0.52
- Average True Range (ATR)
- VVPR 0.13
- AIMD 0.04
- MACD
- VVPR 0.02
- AIMD -0.00
- Stochastic Oscillator
- VVPR 28.79
- AIMD 37.25
About VVPR VivoPower International PLC
Vivopower International PLC is a solar power company. The company provides energy infrastructure generation, and distribution solutions and is also engaged in the development, construction, and sale of photovoltaic(PV) solar projects. Its operating segments include Solar Development, Critical Power Services, Sustainable Energy Solutions Electric Vehicles, and Corporate Office. The majority of the firm's revenue is generated from the Critical Power Services segment which consists of the design, supply, installation, and maintenance of power and control systems. It provides its solutions to government, commercial, and industrial customers. Nearly all of the revenue derives from Australia.
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.